YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Europe and/or Bust


March 20, 2012 | Even though Europe's financial system has been on charging downhill recently, several venture firms have invested heavily in European biotech in recent months. Their argument: the science and the talent exist, and experienced executives are looking for entrepenurial opportunities. But does that really outweigh the negatives? Xconomy
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.